Kaynaklar
[1] Bilkay, B.Ç., 2009. Ege İç Hastalıkları, Güven Kitabevi. İzmir, 399-400 s.
[2] Ekmekçi, A., 2006. Gen Genetik Değişim ve Hastalıklar. Gazi Kitabevi. 217-220 s.
[3] Cooper, G. M., Hausman, R. E., Hücre, 2006, (Çev.:Sakızlı, M.,Atabey,N.). İzmir Tıp Kitabevi, İzmir.
631-64 s.
[4] Lüleyap, H. Ü.,2008. Moleküler Genetiğin Esasları, Nobel Kitabevi. 306-307 s.
[5] Sun, J., 2007. D-limonene: safety and clinical applications. Altern. Med. Rev. 12, 259–264.
[6] Homburger F., Treger A., Boger E., 1970. Inhibition of murine subcutaneous and intravenous
benzo[rst]pentaphene carcinogenesis by sweet orange oils and (+)-limonene. Oncology 25(1): 1–10.
[7] Van Duuren BL, Goldschmidt BM. 1976. Cocarcinogenic and tumor-promoting agents in tobacco
carcinogenesis. J Natl Canc Ins (1940-1978) 56(6): 1237–42.
[8] Sun, J., 2007, D-Limonene:Safety and Clinical Applications, Alternative Medicine Review Volume 12,
,259-264.
[9] Igimi H, Nishimura M, Kodama R, Ide H. Studies on the metabolism of d-limonene (p-mentha-1,8-
diene). I. The absorption, distribution and excretion of d-limonene in rats. Xenobiotica 1974;4:77-84.
[10] Crowell PL, Lin S, Vedejs E, Gould MN. Identification of metabolites of the antitumor agent d-limonene
capable of inhibiting protein isoprenylation and cell growth. Cancer Chemother Pharmacol 1992;31:205-
212.
[11] Vigushin DM, Poon GK, Boddy A, et al. Phase I and pharmacokinetic study of d-limonene in patients
with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother
Pharmacol 1998;42:111-117.
[12] Elegbede JA, Elson CE, Qureshi A, et al. Inhibition of DMBAinduced mammary cancer by the
monoterpene d-limonene. Carcinogenesis 1984;5:661-664.
[13] Wattenberg LW. Inhibition of neoplasia by minor dietary constituents. Cancer Res
1983;43:2448S-2453S.
[14] Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr 1999;129:775S-778S.
[15] Yano H, Tatsuta M, Iishi H, et al. Attenuation by d-limonen of sodium chloride-enhanced gastric
carcinogenesis induced by N-methyl-N’-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 1999;82:665-
668.
[16] Dietrich DR, Swenberg JA. The presence of alpha 2u-globulin is necessary for d-limonene promotion of
male rat kidney tumors. Cancer Res 1991;51:3512-3521.
[17] Wattenberg LW, Coccia JB. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
carcinogenesis in mice by d-limonene and citrus fruit oils. Carcinogenesis 1991;12:115-117.
[18] Van der Logt EM, Roelofs HM, van Lieshout EM, et al. Effects of dietary anticarcinogens and
nonsteroidal anti-inflammatory drugs on rat gastrointestinal UDP-glucuronosyltransferases. Anticancer Res
2004;24:843-849.
Leyla Yeşilçınar
Kimyager (Doktora Öğrencisi)
leylayasilcinar@stu.comu.edu.tr
14